A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
Keywords: Bladder cancer; PD-L1 inhibitor; PD-1 inhibitor; BCG; Immunotherapy;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Enhanced expression of PD-L1 and IFN-γ on dendritic cells is associated with BCG-induced Th2 inhibition
Keywords: BCG; Mycobacterium bovis bacillus Calmette-Guérin; DC; dendritic cells; HE; hematoxylin and eosin; OVA; ovalbumin; PD; programmed death; PD-L; programmed death ligand; SR; sirius red; TLRs; tool-like receptors; TSLP; thymic stromal lymphopoietin; Treg; r
Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses
Keywords: Newborn; dendritic cells; Toll-like receptor 8; polymersome; nanoparticle; BCG; vaccine; Ag85B; Antigen 85B; APC; Antigen-presenting cell; BMDC; Bone marrow-derived dendritic cell; DC; Dendritic cell; FITC; Fluorescein isothiocyanate; HBV; Hepatitis B v
A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation
Keywords: Tuberculosis; Subunit vaccine; CMFO-DMT; Primary infection; Latent infection; Reactivation; TB; tuberculosis; LTBI; latent tuberculosis infection; ATB; active TB patient; BCG; Mycobacterium bovis Bacillus Calmette-Guerin; CTT3H; CFP10-TB10.4-TB8.4-Rv3615-
Remodeling the Th1 polarized systemic environment contributes to neurogenesis and cognitive function via the Wnt7a pathway in neonatal mice
Keywords: BCG; Bacillus Calmette-Guérin; BDNF; brain derived neurotrophic factor; BS; BCG-serum; CFU; colony forming units; CNS; central nervous system; DG; dentate gyrus; ICV; Intracerebroventricular; IF; Immunofluorescence; IGF-1; insulin-like growth factor 1; N
ReviewImmuno-PCR, a new technique for the serodiagnosis of tuberculosis
Keywords: Ag85; antigen 85; ATT; anti-tubercular therapy; BCG; M. bovis bacillus Calmette-Guérin; CRS; composite reference standard; DTT; dithiothreitol; ELISA; enzyme-linked immunosorbent assay; EPTB; extrapulmonary TB; GNP; gold nanoparticles; HIV; human immunod
Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain
Keywords: BCG; Vaccination; AD; Monocytes; IFN-γ; Anti-inflammation;
Specific and cross-reactive immune response against Mycobacterium tuberculosis antigens in mice immunized with proteoliposomes from Mycobacterium bovis BCG
Keywords: BCG; Immunogenicity; Mycobacterium tuberculosis; Proteoliposomes;
Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin
Keywords: postoperative complications; pulmonary embolism; cystectomy; heparin; venous thrombosis; BCG; bacillus Calmette-Guérin; BMI; body mass index; CCI; age adjusted Charlson comorbidity score; DVT; deep vein thrombosis; EBL; estimated blood loss; GFR; glomer
Review articleBrain interference: Revisiting the role of IFNγ in the central nervous system
Keywords: AMPA; amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; APC; antigen-presenting cell; APP; amyloid processing protein; Aβ; amyloid-β; BBB; blood-brain barrier; BCG; bacillus Calmette-Guérin; BCSFB; blood-cerebrospinal fluid barrier; BDNF; brain-der
Pilot studies of a human BCG challenge model
Keywords: BCG; Bacillus Calmette-Guerin; TB; Tuberculosis;
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab
Keywords: CT; computer tomography; PET; positron emission tomography; RS3PE; remitting seronegative symetrical synovitis with pitting edema; PD-1; programmed cell-death-1; PDL-1; programmed cell-death ligand-1; CRP; C-reactive protein; CCP; cyclic citrullinated pep
Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer
Keywords: AKT; AKT serine/threonine kinase 1; BCG; bacillus Calmette-Guérin; CTLA4; cytotoxic T-lymphocyte-associated protein 4; EGFR; epidermal growth factor receptor; FDA; Food and Drug Administration; FGFR; fibroblast growth factor receptor; GC; gemcitabine p
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications
Keywords: bladder neoplasms; neoplasm grading; neoplasm invasiveness; CD274 protein; human; urothelium; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; HGT1; high grade T1 bladder cancer; MIBC; muscle invasive bladder cancer; NMIBC; nonMIBC; PD-1; programme
Construction of human MASP-2-CCP1/2SP, CCP2SP, SP plasmid DNA nanolipoplexes and the effects on tuberculosis in BCG-infected mice
Keywords: Liposome; Nanolipoplexes; Infection; MASP-2; Granuloma; BCG;
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
Keywords: bladder neoplasms; neoplasm recurrence; local; androgen antagonists; prevention and control; 5-alpha reductase inhibitors; ADT; androgen deprivation therapy; AR; androgen receptor; AST; androgen suppression therapy; BCG; bacillus Calmette-Guérin; BPH; be
Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis
Keywords: urinary bladder neoplasms; BCG vaccine; immunotherapy; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; FDA; United States Food and Drug Administration; MeSH; Medical Subject Headings; NMIBC; nonmuscle invasive bladder cancer; PRISMA; Preferred Rep
The Long-term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing
Keywords: BCG vaccine/therapeutic use; false positive reactions; latent tuberculosis; tuberculin test; tuberculosis; tuberculosis epidemiology; BCG; Bacille Calmette-Guérin; CDC; Centers for Disease Control and Prevention; HR; hazard ratio; IGRA; interferon-gamma
Cervicofacial non-tuberculous mycobacteria: A report of 30 cases
Keywords: Lymphadenitis; Non-tuberculous mycobacteria; BCG; Adenopathy; Parotitis; Clarithromycin
Mycobactéries atypiques de localisation cervico-faciale : à propos de 30 cas
Keywords: Lymphadénite; Mycobactérie atypique; BCG; Adénopathie; Parotidite; Clarithromycine
Post-exposure vaccination with the vaccine candidate Bacillus Calmette–Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis
Keywords: BCG; VPM1002; Post-exposure vaccination
Bacillus Calmette-Guérin vaccination at birth: Effects on infant growth. A randomized clinical trial
Keywords: BCG; Child growth; Inflammation; Body composition; Non-specific effect; Obesity;
MycobacteriologyDifferences between a probable and proven BCG infection following intravesical instillations: 16 years experience in a tertiary care hospitalâ
Keywords: Transurethral resection; BCG; Mycobacterium bovis; Infection;
Assessment of safety and interferon gamma responses of Mycobacterium bovis BCG vaccine in goat kids and milking goats
Keywords: BCG; Tuberculosis; Goats; Safety; Interferon gamma; DIVA;
Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial
Keywords: BCG; Adverse reactions; Vaccines; Clinical trials; Non-specific effects; Children;
TLR9 played a more important role than TLR2 in the combination of maltose-binding protein and BCG-induced Th1 activation
Keywords: Maltose-binding protein; MBP; BCG; Th1 activation; TLR2/9 cross-talk;
Therapeutic Use of Mitomycin C for Urological Conditions: Systematic Review of the Literature
Keywords: urethra; urinary bladder neoplasms; mitomycin; anticarcinogenic agents; urological agents; BCG; bacillus Calmette-Guérin; BNC; bladder neck contracture; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer;
Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON®-TB Gold (+) Kenyan adults without evidence of tuberculosis
Keywords: Tuberculosis; Vaccine; AERAS-402; Safety; Immunity; Adenovirus-vectored; AE; adverse event; Ad; adenovirus; ALT; alanine aminotransferase; BCG; bacillus Calmette-Guérin; CPK; creatine phosphokinase; Mtb; Mycobacterium tuberculosis; PPD; purified protein
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer
Keywords: Device-assisted therapy; Hyperthermia; Intravesical chemotherapy; Thermochemotherapy; Radiofrequency; Mitomycin-C; BCG; Non-muscle-invasive bladder cancer; Recurrence rate; Randomised controlled trial;
An algorithm for beat-to-beat heart rate detection from the BCG based on the continuous spline wavelet transform
Keywords: BCG; Heart rate; Wavelet transform;
Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status
Keywords: Tuberculosis; BCG; IFN-γ; Immune response;
Boosting BCG with inert spores improves immunogenicity and induces specific IL-17 responses in a murine model of bovine tuberculosis
Keywords: Bovine tuberculosis; Vaccine; Spores; BCG; Heterologous prime-boost;
DNA vaccination boosts Bacillus Calmette–Guérin protection against mycobacterial infection in zebrafish
Keywords: Zebrafish; Tuberculosis; BCG; Vaccine; Mycobacterium marinum
Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants
Keywords: BCG; T-cells; Cytokines; Infants; Polyfunctional; Mycobacterial growth inhibition; BCG; Bacillus Calmette-Guerin; PPD; purified protein derivative; SEB; Staphylococcus enterotoxin B; TB; tuberculosis; NTM; non-tuberculous mycobacteria; IQR; interquartile
Enhanced protective efficacy against tuberculosis provided by a recombinant urease deficient BCG expressing heat shock protein 70-major membrane protein-II having PEST sequence
Keywords: Ag; antigen; APC; antigen-presenting cell; BCG; Mycobacterium bovis BCG; HSP; heat shock protein; MTB; Mycobacterium tuberculosis; MMP; major membrane protein; DC; dendritic cell; r; recombinant; Recombinant BCG; Tuberculosis; Vaccine;
The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection
Keywords: Tuberculosis; Ag85B; BCG; Macrophages; Vaccine;
Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants
Keywords: BCG; Humoral immunity; Infants; HIV-exposed; South Africa;
Données comparatives moléculaires, précliniques et cliniques des différentes souches de bacille de Calmette-Guérin (BCG) : revue de la littérature du Comité de cancérologie de l’Association française d’urologie (CCAFU)
Keywords: BCG; Vessie; Souche; Génome; Cytotoxicité; Réaction immunitaire; Efficacité; ToléranceBCG; Bladder; Strain; Genome; Cytotoxicity; Immune response; Efficiency; Safety
BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice
Keywords: Atherosclerosis; BCG; Hepatitis; Hypercholesterolemia;
Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB
Keywords: BCG; Adenovirus; Prime-boost; Tuberculosis; Protection; Parenteral vaccination;
Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines
Keywords: TB; tuberculosis; DDA; dimethyldioctadecylammonium bromide; CBA; cytometry bead array; BCG; Bacillus Calmette-Guerin; PHB; Poly(3-hydroxybutyrate); PhaA; β-ketothiolase; PhaB; acetoacetyl-CoA reductase; PhaC; PHB synthase; APCs; antigen presenting cell
Research reportNeonatal BCG vaccination of mice improves neurogenesis and behavior in early life
Keywords: BCG; Bacillus Calmette-Guérin; BDNF; brain-derived neurotrophic factor; BrdU; 5-bromo-2-deoxy uridine; CNS; central nervous system; Dcx; doublecortin; DG; dentate gyrus; EPM; elevated plus maze; GFAP; glial fibrillary acidic protein; Iba-1; ionized cal
Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study
Keywords: Tuberculosis; M72/AS01E vaccine; Safety; Immunogenicity; T-cell; AE; adverse event; ATP; according to protocol; BCG; Bacille Calmette-Guérin; CFP10; culture filtrate protein-10; CI; confidence interval; CMI; cell-mediated immunity; ELISA; enzyme linked i
Dietary zinc deficiency impairs humoral and cellular immune responses to BCG and ESAT-6/CFP-10 vaccination in offspring and adult rats
Keywords: ZIP2; ZIP8; BCG; ESAT-6/CFP-10;
Complications dans les suites d'une BCG thérapie intravésicale : épidémiologie, description clinique et prise en charge
Keywords: BCG; BCGite; Mycobacterium bovis; Cancer de vessie; Instillation intravésicale; BCG; BCGitis; Mycobacterium bovis; Bladder cancer; Intravesical instillation;
Pre-clinical toxicity and immunogenicity evaluation of a MUC1–MBP/BCG anti-tumor vaccine
Keywords: Mucin 1; BCG; Anti-tumor; Vaccine; Toxicity; Immunogenicity
Immune deficiencies, infection, and systemic immune disordersMycobacterial disease in patients with chronic granulomatous disease: AÂ retrospective analysis of 71 cases
Keywords: Mycobacteria; BCG; chronic granulomatous disease; tuberculosis; primary immunodeficiency; AR; Autosomal recessive; CGD; Chronic granulomatous disease; EM; Environmental mycobacteria; MSMD; Mendelian susceptibility to mycobacterial disease; NADPH; Nicotina
Layer-by-layer nanocoating of live Bacille-Calmette-Guérin mycobacteria with poly(I:C) and chitosan enhances pro-inflammatory activation and bactericidal capacity in murine macrophages
Keywords: Bacille Calmette-Guérin (BCG); Bone marrow-derived macrophages; Layer-by-layer nanocoating; Nitric oxide (NO); Polyinosinic-polycytidylic acid (poly(I:C)); BCG; Bacille Calmette-Guérin; CFU; colony forming units; LbL; Layer-by-layer; PAMPs; Pathogen-ass
The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis
Keywords: urinary bladder neoplasms; BCG vaccine; treatment failure; cystectomy; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CSS; cancer specific survival; HG; high grade; IFN; interferon; IVT; intravesical therapy; LVI; lymphovascular invasi
Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations
Keywords: Tuberculosis; BCG; Biomarkers; Non-human primate; Aerosol challenge;